Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...

The MM120 ODT Phase 3 clinical development program also includes the Voyage study for GAD and the Emerge study for major depressive disorder (MDD). The U.S. Food and Drug Administration has granted ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

Individuals with high insomnia, depression, anxiety, and fatigue scores were significantly more likely to have exploding head syndrome.

Her work has previously appeared in Billboard and Reader's Digest. Jamie McCarthy/WireImage Josh Gad shared that he’s taking a GLP-1 medication for weight loss, praising it as a “miracle drug ...

If you prefer communicating by text, Crisis Text Line offers support through text messaging 24/7 ... anxiety. NIH National Institute of Mental Health. Anxiety disorders. Eagleson C, Hayes S, Mathews A ...

"It was amazing to have that opportunity to just sit with him," Gad said, describing the reunion as "very cathartic" Erin Clack is a Staff Editor for PEOPLE. She has been writing about fashion ...

Many celebrities have joined the ranks of those who swear by the medication, including Josh Gad, who opened up about his experience for the first time this week. Gad revealed that he was taking ...

Anxiety can sometimes cause physical symptoms like chest pain and pressure. But because these symptoms can also indicate heart conditions, it’s important to get an accurate diagnosis. Many ...

Josh Gad is reflecting on the "cathartic" experience of reconnecting with his father after a 20-year estrangement. During an appearance on the Jan. 16 episode of SiriusXM's The Spotlight with ...

Is climate anxiety interfering with your life? Climate anxiety refers to ongoing feelings of fear, guilt, and grief related to environmental changes caused by climate change. In some cases ...

Researchers conducted a network analysis of longitudinal data examining the relationship between psychotic-like experiences and social defeat occurrences in young adults.